Breast Cancer Trial, Recruiting NCT07200427 Sponsor: Harokopio University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07200427
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the MELIORA-HEALTHY group (women without a cancer diagnosis):

  • Living in Greece, Lithuania, or Spain.
  • Female and 18 years of age or older.
  • Having access to a smartphone (iPhone or Android) that works with the MELIORA app, and being able to use it throughout the study.
  • Being willing to use the MELIORA app for the full length of the study.
  • Being willing to give formal consent to take part.
  • Having at least one of these lifestyle or health risk factors: drinking more than one alcoholic drink per day on average; having a BMI of 25 or higher, or a waist measurement of 80 cm or more; not doing at least 150 minutes of moderate exercise or 75 minutes of intense exercise per week in the past month; or having a low-quality diet based on a standard screening tool used by the trial.

For the MELIORA-PATIENTS group (women currently dealing with breast cancer):

  • Living in Spain or Lithuania.
  • Female and 18 years of age or older.
  • Having access to a compatible smartphone and being able to use the MELIORA app throughout the study.
  • Being willing to use the MELIORA app for the full length of the study.
  • Being willing to give formal consent to take part.
  • Having been diagnosed with breast cancer within the last 6 months, and/or currently receiving treatment (such as chemotherapy, radiotherapy, immunotherapy, or hormone therapy), and/or being in active medical follow-up.
  • Having at least one of the same lifestyle or health risk factors listed above for the Healthy group.

For the MELIORA-SURVIVORS group (women who have finished breast cancer treatment):

  • Living in Spain, Lithuania, or Sweden.
  • Female and 18 years of age or older.
  • Having access to a compatible smartphone and being able to use the MELIORA app throughout the study.
  • Being willing to use the MELIORA app for the full length of the study.
  • Being willing to give formal consent to take part.
  • Having completed main breast cancer treatment (such as surgery, chemotherapy, or radiotherapy) and currently being in remission.
  • Being considered cancer-free by their treating doctor, with the possibility of joining the study immediately after receiving that assessment.
  • Ongoing hormone therapy taken after the main treatment is still permitted.
  • Having at least one of the same lifestyle or health risk factors listed above for the Healthy group.

Who may not be able to join:

For the MELIORA-HEALTHY group:

  • People who are unable to give fully informed consent.
  • People who cannot understand or communicate in the official language of the country where they would be enrolled (Greek in Greece, Lithuanian in Lithuania, Spanish in Spain).
  • People with a current or past diagnosis of any cancer, or an uncontrolled long-term illness (such as heart disease or diabetes) that affects lifestyle, diet, or communication.
  • People with a mental illness or disorder that affects lifestyle, diet, or communication.
  • People taking medication that affects lifestyle, diet, or communication.
  • People who use recreational drugs.
  • People who are pregnant, breastfeeding, or planning to become pregnant around the time of the study.
  • People already taking part in another clinical trial or program focused on behaviour change or weight loss at the time of joining; those using health-related apps that affect weight or lifestyle may be asked to stop using them for the 12-month study period (confirm with trial site).

For the MELIORA-PATIENTS and MELIORA-SURVIVORS groups:

  • People who are unable to give fully informed consent.
  • People who cannot understand or communicate in the local language (Lithuanian, Spanish, or Swedish depending on the country), unless appropriate translation support is available to ensure full understanding (confirm with trial site).
  • People with a current or past diagnosis of any cancer other than breast cancer — except skin cancer that was treated with surgery only — or an uncontrolled long-term illness (such as heart disease or diabetes) that affects lifestyle, diet, or communication.
  • People with a mental illness or disorder that affects lifestyle, diet, or communication.
  • People taking medication that affects lifestyle, diet, or communication.
  • People who use recreational drugs.
  • People who are pregnant, breastfeeding, or planning to become pregnant around the time of the study.
  • People already taking part in another clinical trial or program focused on behaviour change or weight loss; those using health-related apps that affect weight or lifestyle may be asked to stop using them for the 12-month study period (confirm with trial site).
  • People with a history of serious difficulty following through with previous treatments, where the treating doctor believes this could affect their ability to complete study tasks.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yannis Manios, Professor, Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece

Phone: +30 2109549156

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Harokopio University
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 September 2027

Where this trial is recruiting

🇬🇷 Greece 🇱🇹 Lithuania 🇪🇸 Spain 🇸🇪 Sweden

Primary endpoints

Physical activity levels - MVPA minutes; Physical activity levels - Step count

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov